Multiple intraosseous hemangiomas—investigation and role of N‐butylcyanoacrylate in management

Background. Primary intraosseous hemangiomas are rare (0.7% of all osseous neoplasms), benign, slow‐growing neoplasms. These lesions are usually solitary. We are reporting a case of multicentric intraosseous hemangiomas. Investigation, treatment options, and role of N‐butylcyanoacrylate (NBCA) in ma...

Full description

Saved in:
Bibliographic Details
Published inHead & neck Vol. 29; no. 5; pp. 512 - 517
Main Authors Syal, Rajan, Tyagi, Isha, Goyal, Amit, Barai, Sukanto, Parihar, Anit, Kraus, Dennis H.
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.05.2007
John Wiley & Sons
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background. Primary intraosseous hemangiomas are rare (0.7% of all osseous neoplasms), benign, slow‐growing neoplasms. These lesions are usually solitary. We are reporting a case of multicentric intraosseous hemangiomas. Investigation, treatment options, and role of N‐butylcyanoacrylate (NBCA) in management will be discussed. Methods and Results. A 20‐year‐old man had multicentric intraosseous hemangiomas involving the skull bones, mandible, vertebra, pelvic bone, and tibial tuberosity. N‐butylcyanoacrylate was used by direct puncture technique using a transosseous transcutaneous route to control profuse bleeding from the retromolar region. Conclusion. To the best of our knowledge, this is the first reported case with such extensive multicentric intraosseous hemangiomas. N‐butylcyanoacrylate by direct puncture technique can be an effective method to devascularize and stabilize low‐flow intraosseous vascular tumors. © 2007 Wiley Periodicals, Inc. Head Neck, 2007
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ObjectType-Article-2
ObjectType-Feature-1
ISSN:1043-3074
1097-0347
DOI:10.1002/hed.20539